AI Verdict
EVGN has stronger fundamentals based on our AI analysis.
EVGN vs EVFM Fundamental Comparison
| Metric | EVGN | EVFM |
|---|---|---|
| Revenue | N/A | $20.2M |
| Net Income | N/A | $391,000.0 |
| Net Margin | N/A | 1.9% |
| ROE | N/A | N/A |
| ROA | N/A | 1.9% |
| Current Ratio | N/A | 0.18x |
| Debt/Equity | N/A | N/A |
| EPS | N/A | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVGN vs EVFM: Frequently Asked Questions
Is EVGN or EVFM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EVGN has stronger fundamentals. EVGN is rated SELL (85% confidence) while EVFM is rated STRONG SELL (92% confidence). This is not investment advice.
How does EVGN compare to EVFM fundamentally?
Evogene Ltd. has ROE of N/A vs Evofem Biosciences, Inc.'s N/A. Net margins are N/A vs 1.9% respectively.
Which stock pays higher dividends, EVGN or EVFM?
EVGN has a dividend yield of N/A or no dividend while EVFM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVGN or EVFM for long term?
For long-term investing, consider that EVGN has SELL rating with 85% confidence, while EVFM has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVGN vs EVFM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVGN vs EVFM, the AI consensus favors EVGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.